Today Incyte (Nasdaq:INCY) announced that it will present new data from its dermatology portfolio at the European Association of Dermatology and Venerology (EADV) 2025 Congress, held from September 17 – 20, in Paris. Highlights include late-breaking, oral and poster presentations featuring data for povorcitinib (INCB054707), an oral small-molecule JAK1 inhibitor, and ruxolitinib cream (Opzelura®), a topical JAK1/2 inhibitor. “Our presence at EADV demonstrates the significant progress across o...

Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the launch of ProParts+, a new addition to the company’s industry-leading ProAdvantage support programs, designed specifically for Cessna Citation 525 series operators. ProParts+ builds on the trusted foundation of the ProParts program, offering expanded coverage to address key customer identified priorities and enhance operational predictability. This press release features multimedia. View the full release here: https...